CLINICAL_TRIALS
trial_result
· 2023-08-07
Clinical Trial Update: To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis [Phase 2]
Summary
Phase 2 clinical trial evaluating Hallux terbinafine subungual gel for treating onychomycosis of the toenail.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hallux, Inc. | Conditions: Onychomycosis of Toenail | Phase 2 | Status: UNKNOWN